Onderzoeker
Bouke de Jong
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf1 sep 2010 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 aug 2010 → 16 apr 2015
Projecten
1 - 10 of 75
- Can tongue swabs be used to isolate viable Mycobacterium tuberculosis bacilli from PTBVanaf12 dec 2022 → 15 dec 2023
- Omics Data Integratie om antimicrobiële resistentie in Mycobacterium tuberculosis te voorspellenVanaf27 apr 2022 → Heden
- Rwandese instituten tot leiders maken op het gebied van preventie, diagnose en bestrijding van infectieziektenVanaf1 jan 2022 → Heden
- Consolidatie en beheer van het BCCM Consortium als "Belgisch Research Center"Vanaf1 jan 2022 → Heden
- Rapid diagnosis of Mycobacterium tuberculosis resistance, beyond rifampicinVanaf1 jan 2022 → Heden
- TB/NTM OnderzoeksclusterVanaf1 jan 2022 → Heden
- Versterking van de onderzoeks- en onderwijscapaciteit in de partnerinstituten (INRB, CRSK, ESP) in de DRC (OC1) - Ondersteuning van de stopzetting van de overdracht van humane Afrikaanse Trypanosomiasis (HAT) tegen 2030 (OC2)Vanaf1 jan 2022 → Heden
- Multi Omics Data Integration to predict the M. tuberculosis Bedaquiline Resistance Phenotype from the GenotypeVanaf1 jan 2022 → Heden
- Culture-free approaches including whole genome sequencing in support of diagnostic and transmission studies on MycobacteriumVanaf30 jun 2021 → Heden
- Beteugeling van rifampicineresistente tuberculose in Rwanda en daarbuitenVanaf30 jun 2021 → Heden
Publicaties
31 - 40 van 172
- Thin-layer-agar-based direct phenotypic drug susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance otherwise missed by WHO-endorsed diagnostic tests(2021)
Auteurs: Elisa Ardizzoni, E. Ariza, D. Mulengwa, Q. Mpala, R de la Tour, Gugu Maphalala, F. Varaine, Bernhard Kerschberger, Pieter Graulus, A-L Page, et al.
- Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?(2021)
Auteurs: Sabira Tahseen, Armand Van Deun, Bouke de Jong, T Decroo
Pagina's: 831-835 - Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown(2021)
Auteurs: Armand Van Deun, T Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, M Gumusboga, P De Rijk, Sabira Tahseen, Bouke de Jong, Leen Rigouts
- Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history(2021)
Auteurs: Mireia Coscolla, Sebastien Gagneux, Fabrizio Menardo, Chloe Loiseau, Paula Ruiz-Rodriguez, Sonia Borrell, Isaac Darko Otchere, Adwoa Asante-Poku, Prince Asare, Leonor Sanchez-Buso, et al.
- Predictors of rifampicin-resistant tuberculosis mortality among HIV-coinfected patients in Rwanda(2021)
Auteurs: Dominique Savio Habimana, Jean Claude Semuto Ngabonziza, Patrick Migambi, Yves Mucyo Habimana, Grace Mutembayire, Francine Byukusenge, Innocent Habiyambere, Eric Remera, Placidie Mugwaneza, Ivan Emil Mwikarago, et al.
Pagina's: 47-53 - High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss(2021)
Auteurs: Mahamadou Bassirou Souleymane, Alberto Piubello, Ibrahim Mamane Lawan, Souleymane Hassane-Harouna, Mourtala Mohamed Assao-Neino, Alphazazi Soumana, Zelika Hamidou-Harouna, Assiatou Gagara-Issoufou, Nimer Ortuno-Gutierrez, Alberto Roggi, et al.
- Low cycle threshold value in Xpert MTB/RIF assay may herald false detection of tuberculosis and rifampicin resistance: a study of two cases(2021)
Auteurs: Jean Claude Semuto Ngabonziza, T Decroo, Rodrigue Maniliho, Yves Mucyo Habimana, Armand Van Deun, Bouke de Jong
- Human rights: finding the right balance for rifampicin-resistant TB treatment(2021)
Auteurs: Armand Van Deun, A Piubello, L Lynen, Bouke de Jong, T Decroo
Pagina's: 327-328 - Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens(2021)
Auteurs: Nicholas D Walter, Sarah E. M. Born, Gregory T. Robertson, Matthew Reichlen, Christian Dide-Agossou, Victoria A. Ektnitphong, Karen Rossmassler, Michelle E. Ramey, Allison A. Bauman, Victor Ozols, et al.
- Quantifying transmission fitness costs of multi-drug resistant tuberculosis(2021)
Auteurs: Julija Pecerska, Denise Kuehnert, Conor J. Meehan, Mireia Coscolla, Bouke de Jong, Sebastien Gagneux, Tanja Stadler